Brief: Dancann Pharma Says Louise Conradsen Appointed As CEO Of Subsidiary Canngros ApS
12/04/2022 22:16
April 12 (Reuters) - Dancann Pharma A/S DANCAN.TE :
* DANCANN PHARMA - LOUISE CONRADSEN IS APPOINTED AS CEO OF
SUBSIDIARY, CANNGROS APS
* JEPPE KROG RASMUSSEN REMAINS CEO OF DANCANN PHARMA A/S
Source text for Eikon: ID:nWkr2nlwcz
Further company coverage: DANCAN.TE
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dancann Pharma A/S
See all newsBrief: Dancann Pharma Says Jeppe Krog Rasmussen Resigns As CEO
Brief: Dancann Pharma Says Resolved To Apply For Delisting From Spotlight Stock Market, Subject To Approval By The General Meeting
Brief: Dancann Pharma Says Rights Issue Has Been Subscribed For A Total Of Approximately 77%
Brief: Dancann Pharma A/S Postpones Quarterly Report For Q2 2022
Brief: Dancann Pharma Reports Q1 Net Sales KDKK 1,266 Vs KDKK 874